1
|
Ringeisen H, Edlund M, Guyer H, Dever J, Carpenter L, Olfson M, First M, Geiger P, Liao D, Peytchev A, Carr C, Chwastiak L, Dixon LB, Monroe-Devita M, Scott Stroup T, Swanson J, Swartz M, Gibbons R, Stambaugh L, Bareis N, Smith TE, Kessler RC. Prevalence of Past-Year Mental and Substance Use Disorders, 2021-2022. Psychiatr Serv 2025:appips20240329. [PMID: 40395079 DOI: 10.1176/appi.ps.20240329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/22/2025]
Abstract
OBJECTIVE The authors aimed to estimate the past-year prevalence of mental and substance use disorders, including schizophrenia spectrum disorders (schizophrenia, schizoaffective, or schizophreniform disorder), among U.S. adults ages 18-65 years from samples of households and prisons and stratified samples from selected homeless shelters and state psychiatric hospitals. Such information is vital to meet the treatment needs of individuals with these disorders. METHODS The Mental and Substance Use Disorders Prevalence Study (MDPS) was conducted between October 2020 and October 2022. Interviewers administered a structured clinical interview for the DSM-5 (N=5,679 participants; N=4,764 in households). Weighted past-year prevalence estimates of mental and substance use disorders were calculated. Level of impairment and the likelihood that a disorder was caused by the COVID-19 pandemic were assessed. RESULTS The prevalence estimates of lifetime and past-year schizophrenia spectrum disorders were 1.8% (95% CI=1.3%-2.5%) and 1.2% (95% CI=0.9%-1.8%), respectively. The most common past-year disorders were major depressive disorder (15.5%, 95% CI=13.6%-17.5%) and generalized anxiety disorder (GAD; 10.0%, 95% CI=8.3%-12.1%). About one in 10 participants had at least one substance use disorder (10.6%, 95% CI=8.7%-12.9%). Half of those with an MDPS mental disorder had moderate or serious impairment. CONCLUSIONS The prevalence rates of lifetime and past-year schizophrenia spectrum disorders were two to four times higher than previously reported. The prevalence rates of major depressive disorder and GAD were substantially higher than reported in past national studies. Almost 20% of these cases were likely due to the pandemic. Increased mental health treatment resources are urgently needed.
Collapse
Affiliation(s)
- Heather Ringeisen
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Mark Edlund
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Heidi Guyer
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Jill Dever
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Lisa Carpenter
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Mark Olfson
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Michael First
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Paul Geiger
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Dan Liao
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Andy Peytchev
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Christine Carr
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Lydia Chwastiak
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Lisa B Dixon
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Maria Monroe-Devita
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - T Scott Stroup
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Jeff Swanson
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Marvin Swartz
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Robert Gibbons
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Leyla Stambaugh
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Natalie Bareis
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Thomas E Smith
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| | - Ronald C Kessler
- RTI International, Research Triangle Park, North Carolina (Ringeisen, Edlund, Guyer, Dever, Carpenter, Geiger, Liao, Peytchev, Carr, Stambaugh); Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City (Olfson); New York State Psychiatric Institute, Columbia University Irving Medical Center, New York City (First, Dixon, Stroup, Bareis, Smith); Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle (Chwastiak, Monroe-Devita); Duke Health, School of Medicine, and the Wilson Center for Science and Justice, School of Law, Duke University, Durham, North Carolina (Swanson, Swartz); Center for Health Statistics, University of Chicago, Chicago (Gibbons); Department of Health Care Policy, Harvard Medical School, Boston (Kessler)
| |
Collapse
|
2
|
Berkout OV, Barena E. Mental Health Shortfalls: Perceptions of Unmet Needs and Barriers and Facilitators to Receiving Care. ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH 2025:10.1007/s10488-025-01438-x. [PMID: 40153172 DOI: 10.1007/s10488-025-01438-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/19/2025] [Indexed: 03/30/2025]
Abstract
Understanding the perspectives of individuals with mental health concerns and the influence of barriers and facilitators on treatment access can help mental health professionals ensure that those they serve receive needed care. The current study examined these factors in an online survey among 295 adults self-identifying as diagnosed with a mental health condition, which they felt was uncontrolled by intervention or psychiatric medication and impacted their daily lives. Most participants were not receiving psychotherapy or psychiatric medication, although some were accessing care and indicating unmet needs. A majority expressed a desire for more specialized care. Positive perception of providers, higher distress, and greater stigma tolerance were related to greater openness towards receiving psychotherapy and greater openness to psychotherapy, higher distress, and lower perceived barriers were associated with psychotherapy receipt. The relationship between openness towards psychotherapy and receipt was also stronger for those who perceived lower barriers to care. Advocacy and efforts to promote positive attitudes and reduce barriers by mental health practitioners and professional organizations may help support treatment access.
Collapse
Affiliation(s)
- Olga V Berkout
- Department of Psychology and Counseling, University of Texas at Tyler, 3900 University Blvd, Tyler, TX, 75799, USA.
| | - Emily Barena
- Department of Psychology and Counseling, University of Texas at Tyler, 3900 University Blvd, Tyler, TX, 75799, USA
| |
Collapse
|
3
|
Wiemers EE, Monnat SM, Wolf DA, Montez JK, Grove J, Gutin I, Grossman E. States' COVID-19 policy contexts and suicide rates among US working-age adults. HEALTH AFFAIRS SCHOLAR 2025; 3:qxaf024. [PMID: 40092402 PMCID: PMC11909630 DOI: 10.1093/haschl/qxaf024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Revised: 01/31/2025] [Accepted: 02/25/2025] [Indexed: 03/19/2025]
Abstract
Despite expectations that suicide rates would surge during the pandemic, the national suicide rate declined in the United States in 2020 before returning to pre-pandemic levels in 2021. Explanations of the decline in suicides at the national level include a "pulling-together effect" in the face of a crisis and a shorter than expected pandemic recession. However, suicide rates and the change over time in suicide rates vary substantially across US states. At various times during the pandemic states enacted physical-distancing and economic support policies that may have affected suicide rates. We examined the association between state-level physical-distancing and economic support policy contexts and suicide rates among US adults ages 25-64 years during the COVID-19 pandemic. We found that a 1-SD increase in the stringency of a state's physical-distancing policies was associated with a 5.3% reduction in male suicide rates but was not associated with female suicide rates. Economic support policies were not associated with suicide rates for the period as a whole. The results support the growing evidence that COVID-19 policies had indirect and unintended consequences beyond their direct effect on COVID-19 transmission and death, in this case to reduce suicides among working-age males.
Collapse
Affiliation(s)
- Emily E Wiemers
- Department of Public Administration and International Affairs, Aging Studies Institute, and Center for Aging and Policy Studies, Syracuse University, Syracuse, NY 13244, United States
| | - Shannon M Monnat
- Department of Sociology, Center for Policy Research, Lerner Center for Public Health Promotion and Population Health, Center for Aging and Policy Studies, Syracuse University, Syracuse, NY 13244, United States
| | - Douglas A Wolf
- Department of Public Administration and International Affairs, Aging Studies Institute, and Center for Aging and Policy Studies, Syracuse University, Syracuse, NY 13244, United States
| | - Jennifer Karas Montez
- Department of Sociology, Aging Studies Institute, Center for Aging and Policy Studies, Lerner Center for Public Health Promotion and Population Health, Syracuse University, Syracuse, NY 13244, United States
| | - Joshua Grove
- Department of Sociology, Syracuse University, Syracuse, NY 13244, United States
| | - Iliya Gutin
- Center for Policy Research, Lerner Center for Public Health Promotion and Population Health, Syracuse University, Syracuse, NY 13244, United States
| | - Elyse Grossman
- Epidemiology Research Branch, National Institute on Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892, United States
| |
Collapse
|
4
|
Boyle J, Dayton J, ZuWallack R, Iachan R, Krugipudi D, Blanco CF. Symptoms of Mental Health Conditions and Their Predictors Among U.S. Adults During the First Year of the COVID-19 Pandemic. Healthcare (Basel) 2025; 13:519. [PMID: 40077082 PMCID: PMC11898436 DOI: 10.3390/healthcare13050519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2025] [Revised: 02/20/2025] [Accepted: 02/22/2025] [Indexed: 03/14/2025] Open
Abstract
Background/Objectives: This study examined the impact of the COVID-19 pandemic on mental health among U.S. adults during its first year, using monthly surveys from March to November 2020. Methods: The primary outcome was the Patient Health Questionnaire four-item (PHQ-4) measure of anxiety and depressive symptoms. Univarite and bivariate analyses were used to provide foundational understanding of key variables. Parametric and non-parametric correlation analyses were conducted to observe the relationship between COVID-19 impacts or risk factors and the frequency of anxiety/depressive symptoms. A series of regression models were fit to assess the impact of pandemic stressors on PHQ-4 scores. Results: There was a statistically significant increase in mean PHQ-4 scores and the proportion of respondents with moderate to severe symptoms (PHQ-4 = 6+) between March-June and July-November 2020. Factors such as fear of contracting the virus, health concerns, and lifestyle disruptions had statistically significant impacts on mental health outcomes; however, these effects were more modest than estimates reported elsewhere. Financial strain, particularly among lower-income households and those experiencing job loss, showed stronger associations with increased anxiety and depressive symptoms, but the overall impact on population-level mental health was limited due to the small proportion severely affected financially. Using regression models, we found that demographic factors and pandemic stressors collectively explained about 21% of the variance in anxiety and depressive symptoms. Conclusions: This study provides a nuanced understanding of the pandemic's mental health impact, suggesting that while certain subgroups were more affected, the overall population level increase in anxiety and depression was less pronounced than previously assumed.
Collapse
Affiliation(s)
| | | | | | | | | | - Caitlin Flouton Blanco
- ICF International, 1902 Reston Metro Plaza, Reston, VA 20190, USA; (J.B.); (J.D.); (R.Z.); (R.I.); (D.K.)
| |
Collapse
|
5
|
Bazemore AW, Petterson SM, McCulloch KK. US Primary Care Workforce Growth: A Decade of Limited Progress, and Projected Needs Through 2040. J Gen Intern Med 2025; 40:339-346. [PMID: 39443342 PMCID: PMC11802952 DOI: 10.1007/s11606-024-09121-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2024] [Accepted: 10/04/2024] [Indexed: 10/25/2024]
Abstract
BACKGROUND Despite efforts to mitigate a projected primary care physician (PCP) shortage required to meet an aging, growing, and increasingly insured population, shortages remain, compounded by the COVID-19 pandemic, growing inequity, and persistent underinvestment. OBJECTIVE We examined primary care workforce trends over the past decade and revisited projected primary care clinician workforce needs through the year 2040. DESIGN AND PARTICIPANTS Using data from the AMA Masterfile and Medical Expenditure Panel Survey (MEPS), we analyzed trends in the number of primary care physicians (PCPs) and in outpatient PCP visits by age and gender over the past decade. We then used the Medicare PECOS and Physician & Other Practitioners datasets to identify nurse practitioners (NPs) and physician assistants (PAs) in primary care. MEASURES Using these baseline clinician enumerations and projected population growth estimates from the US Census Bureau for the years 2020-2040, we calculated estimated primary care workforce needs by 2040. KEY RESULTS The effects of aging and population growth and baseline shortages in the primary care workforce call for significant increases in the primary care workforce to accommodate rising demands. Office visits to primary care clinicians are projected to increase from 773,606 in 2020 to 893,098 in 2040. We project a need for an additional 57,559 primary care clinicians by 2040. CONCLUSIONS Workforce shortages in primary care continue to expand due to population aging, growth, and heightened rates of clinician burnout & egress.
Collapse
Affiliation(s)
- Andrew W Bazemore
- Center for Professionalism and Value in Healthcare, 1016 16th St NW Suite 700, Washington, DC, 20036, USA.
- American Board of Family Medicine, Lexington, KY, USA.
| | - Stephen M Petterson
- Robert Graham Center for Policy Studies in Family Medicine & Primary Care, Washington, DC, USA
| | - Kade K McCulloch
- Center for Professionalism and Value in Healthcare, 1016 16th St NW Suite 700, Washington, DC, 20036, USA
| |
Collapse
|
6
|
Cozen AE, Hamad R, Park S, Marcus GM, Olgin JE, Faulkner Modrow M, Chiang A, Brandner M, Orozco JH, Azar K, Sudat SEK, Isasi CR, Williams N, Ozluk P, Kitzman H, Knight SJ, Sanchez-Birkhead A, Kornak J, Carton T, Pletcher M. Associations between local COVID-19 policies and anxiety in the USA: a longitudinal digital cohort study. BMJ PUBLIC HEALTH 2025; 3:e001135. [PMID: 40017931 PMCID: PMC11812870 DOI: 10.1136/bmjph-2024-001135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Accepted: 12/16/2024] [Indexed: 03/01/2025]
Abstract
ABSTRACT Introduction A lack of coordinated federal guidance led to substantial heterogeneity in local COVID-19 policies across US states and counties. Local government policies may have contributed to increases in anxiety and mental health disparities during the COVID-19 pandemic. Methods We analysed associations between composite policy scores for containment and closure, public health or economic support from the US COVID-19 County Policy Database and self-reported anxiety scores (Generalised Anxiety Disorder-7) from COVID-19 Citizen Science participants between 22 April 2020 and 31 December 2021. Results In 188 976 surveys from 36 711 participants in 100 counties across 28 states, associations between anxiety and containment and closure policy differed by employment (p<0.0001), with elevated anxiety under maximal policy for people working in hospitality and food services (+1.05 vs no policy; 95% CI: 0.45, 1.64) or arts and entertainment (+0.56; 95% CI 0.15, 0.97) and lower anxiety for people working in healthcare (-0.43; 95% CI -0.66 to -0.20) after adjusting for calendar time, county-specific effects and COVID-19 case rates and death rates. For public health policy, associations differed by race and ethnicity (p=0.0016), with elevated anxiety under maximal policy among participants identifying as non-Hispanic Black (+1.71; 95% CI 0.26, 3.16) or non-Hispanic Asian (+0.74; 95% CI 0.05, 1.43) and lower anxiety among Hispanic participants (-0.63, 95% CI -1.26 to -0.006). Associations with public health policy also differed by gender (p<0.0001), with higher anxiety scores under maximal policy for male participants (+0.42, 95% CI 0.09, 0.75) and lower anxiety for female participants (-0.40, 95% CI -0.67 to -0.13). There were no significant differential associations between economic support policy and sociodemographic subgroups. Conclusions Associations between local COVID-19 policies and anxiety varied substantially by sociodemographic characteristics. More comprehensive containment policies were associated with elevated anxiety among people working in strongly affected sectors, and more comprehensive public health policies were associated with elevated anxiety among people vulnerable to racial discrimination.
Collapse
Affiliation(s)
- Aaron E Cozen
- Dept of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
| | - Rita Hamad
- Department of Social & Behavioral Sciences, Harvard School of Public Health, Boston, Massachusetts, USA
| | - Soo Park
- Dept of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
| | - Gregory M Marcus
- Division of Cardiology, University of California San Francisco, San Francisco, California, USA
| | - Jeffrey E Olgin
- Division of Cardiology, University of California San Francisco, San Francisco, California, USA
| | - Madelaine Faulkner Modrow
- Dept of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
| | - Amy Chiang
- Division of General Internal Medicine, University of California San Francisco, San Francisco, California, USA
| | - Matthew Brandner
- Dept of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
| | - Jaime H Orozco
- Dept of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
| | - Kristen Azar
- Dept of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
- Center for Health Systems Research, Sutter Health, Walnut Creek, California, USA
| | - Sylvia E K Sudat
- Center for Health Systems Research, Sutter Health, Walnut Creek, California, USA
| | - Carmen R Isasi
- Dept of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA
| | - Natasha Williams
- Dept of Population Health, New York University Grossman School of Medicine, New York, New York, USA
| | - Pelin Ozluk
- Elevance Health Inc, Indianapolis, Indiana, USA
| | - Heather Kitzman
- University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Sara J Knight
- Division of Epidemiology, University of Utah, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA
| | | | - John Kornak
- Dept of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
| | - Thomas Carton
- Louisiana Public Health Institute, New Orleans, Louisiana, USA
| | - Mark Pletcher
- Dept of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
- Division of General Internal Medicine, University of California San Francisco, San Francisco, California, USA
| |
Collapse
|
7
|
Covino N, Abelard M, Mahr B, Ibrahim Y, Louis GS. The Behavioral Health Service Corps: An Innovative Model for Workforce Development. Community Ment Health J 2024:10.1007/s10597-024-01434-9. [PMID: 39714562 DOI: 10.1007/s10597-024-01434-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/31/2024] [Accepted: 12/08/2024] [Indexed: 12/24/2024]
Abstract
The increased prevalence of behavioral health problems in the US is intensified by the critical shortage of providers in the field. The historical failure of behavioral health specialties to attract BIPOC students and workers limits leadership, access to quality care, and the generalizability of research findings. Most workforce development programs serve only those with earned graduate degrees. This report describes a service-learning program that is successfully attracting new graduates with bachelor's degrees and culturally diverse professionals into the behavioral health workforce.
Collapse
Affiliation(s)
| | - Marc Abelard
- The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA
| | - Bori Mahr
- Babson College, Wellesley Hills, MA, USA
| | | | | |
Collapse
|
8
|
Menzies V, Webb F, Lyon DE, Pruinelli L, Kelly DL, Jacobs M. Anxiety and depression among individuals with long COVID: Associations with social vulnerabilities. J Affect Disord 2024; 367:286-296. [PMID: 39233251 DOI: 10.1016/j.jad.2024.08.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2024] [Revised: 08/21/2024] [Accepted: 08/31/2024] [Indexed: 09/06/2024]
Abstract
BACKGROUND We examined the association between symptoms of anxiety and depression among individuals with long COVID and five social vulnerabilities (expenses, employment, food insufficiency, housing, and insurance). METHODS Data from the Census Bureau's Household Pulse Survey (HPS) detailing COVID incidence, duration, and symptoms between June 1st and November 14th, 2022 contained versions of the Generalized Anxiety Disorder (GAD-2) and the Patient Health Questionnaire (PHQ-2) questionnaires. Associations between anxiety, depression, and the five social vulnerabilities among respondents from different racial and ethnic groups experiencing long COVID were evaluated using generalized binomial logistic regression. Structural equation models tested whether social vulnerabilities mediated the pathway between race/ethnicity and anxiety/depression. RESULTS Blacks, Asians/others, and Hispanics with long COVID were significantly more likely to report anxiety and depression and various social vulnerabilities than Whites. Anxiety among Blacks was significantly associated with difficulty with expenses [Odds Ratio (OR) = 1.743, 95 % Confidence Interval (CI) = 1.739, 1.747], employment (OR = 1.519, 95 % CI = 1.516, 1.523), and housing (OR = 1.192, 95 % CI = 1.19, 1.194). Anxiety among Hispanics was significantly associated with food insufficiency (OR = 1.048, 95 % CI = 1.044, 1.052). Depression among Blacks was significantly associated with trouble with expenses (OR = 1.201, 95 % CI = 1.198, 1.205) and employment (OR = 1.129, 95 % CI = 1.127, 1.132). Mediation analysis showed that the number of social vulnerabilities partially mediated the association between race and anxiety. LIMITATIONS This retrospective study utilized secondary, observational, self-reported data from the HPS. Therefore, results may not be generalizable outside of the context in which they were collected. CONCLUSIONS The development of tailored programs for population health should address the differential associations of anxiety and depression with social difficulties among racial and ethnic groups.
Collapse
Affiliation(s)
- Victoria Menzies
- Department of Family & Community Health Sciences, University of Florida College of Nursing, 1225 Center Drive, Gainesville, FL 32610, United States of America.
| | - Fern Webb
- Department of Surgery, Center for Health Equity & Engagement Research (CHEER), University of Florida College of Medicine, 653-1 West 8(th) Street, Jacksonville, FL 32209, United States of America
| | - Debra E Lyon
- Professor and Kirbo Endowed Chair, University of Florida College of Nursing, 1225 Center Drive, Gainesville, FL 32610, United States of America
| | - Lisiane Pruinelli
- Department of Family & Community Health Sciences, University of Florida College of Nursing, 1225 Center Drive, Gainesville, FL 32610, United States of America
| | - Debra Lynch Kelly
- Department of Biobehavioral Nursing Science, University of Florida College of Nursing, 1225 Center Drive, Gainesville, FL 31610, United States of America
| | - Molly Jacobs
- Department of Health Services Research, Management and Policy, University of Florida College of Public Health and Health Professions, 1225 Center Drive, Gainesville, FL 32610, United States of America
| |
Collapse
|
9
|
Singh G, Patra S, Upadhyay MK, Srivastava S. Prevalence of common mental disorders and perspective toward mental health in an urban resettlement colony of Delhi, India: A mixed-method study. JOURNAL OF EDUCATION AND HEALTH PROMOTION 2024; 13:370. [PMID: 39679017 PMCID: PMC11639543 DOI: 10.4103/jehp.jehp_1545_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/29/2023] [Accepted: 03/05/2024] [Indexed: 12/17/2024]
Abstract
BACKGROUND The paucity of community-based research and misunderstandings surrounding mental illness in low- and middle-income countries impede the provision of proper care in this domain. The objective of this research was to assess the prevalence of common mental disorders in an urban resettlement colony in Delhi, India, explore associated factors, and understand the community's perspective on mental health. MATERIALS AND METHODS A community-based mixed-method study was conducted in which 130 participants were selected through multistage systematic random sampling and 12 key community members by purposive sampling. To assess the prevalence of common mental disorders, the 20-item Self-Reported Questionnaire (SRQ-20) was used, while the community's viewpoint on mental illness was explored using an in-depth interview guide. The odds ratio (OR) for risk factors was calculated using Pearson's Chi-square test, Fisher's exact test, and multiple logistic regression. For the qualitative component, themes were analyzed and presented. RESULTS The study found an 18.5% prevalence of common mental disorders in the area. Socioeconomic status, hypertension, chronic health conditions, and the impact of the coronavirus disease 2019 (COVID-19) pandemic on personal life were significant predictors (P < 0.05). The qualitative study identified that community members have a negative perspective on mental illness. Women are a vulnerable group because of their susceptibility to violence and certain cultural factors. CONCLUSION Insufficient knowledge and societal stigmatization act as barriers to accessing mental health services. Certain groups, such as people of lower socioeconomic strata, living with a chronic disease are more affected. Targeted interventions are required to address these effectively.
Collapse
Affiliation(s)
- Gaurav Singh
- Department of Community Medicine, University College of Medical Sciences and GTB Hospital, Delhi, India
| | - Somdatta Patra
- Department of Community Medicine, University College of Medical Sciences and GTB Hospital, Delhi, India
| | - Madhu K. Upadhyay
- Department of Community Medicine, University College of Medical Sciences and GTB Hospital, Delhi, India
| | - Shruti Srivastava
- Department of Psychiatry, University College of Medical Sciences and GTB Hospital, Delhi, India
| |
Collapse
|
10
|
Macrynikola N, Chang S, Torous J. Emotion Regulation Self-Efficacy as a Mechanism of Alliance and Outcomes in a Brief, Transdiagnostic Digital Mental Health Intervention: L'auto-efficacité de la régulation des émotions en tant que mécanisme d'alliance et de résultats dans une brève intervention transdiagnostique numérique en santé mentale. CANADIAN JOURNAL OF PSYCHIATRY. REVUE CANADIENNE DE PSYCHIATRIE 2024:7067437241274201. [PMID: 39308411 PMCID: PMC11562972 DOI: 10.1177/07067437241274201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2024]
Abstract
OBJECTIVES Digital mental health interventions have shown promise for alleviating various forms of psychopathology, including depression and anxiety. However, the mechanisms of such interventions remain largely unexplored. The purpose of this study was to investigate a potential mechanistic process through which one hybrid digital mental health intervention (i.e., the Digital Clinic) might operate. We hypothesized that emotion regulation (ER) self-efficacy at the treatment midpoint may mediate the relationship between alliance (i.e., therapeutic alliance and digital alliance) and outcome (i.e., co-morbid symptoms of depression and anxiety) at the treatment endpoint. METHODS Data used in this study came from the Digital Clinic, a brief transdiagnostic telehealth treatment program augmented by a dual-purpose digital phenotyping and intervention smartphone app. Recruited primarily from primary care, participants were 82 adults (73% White, 64% cisgender women, mean age 41) receiving outpatient treatment in the northeastern United States. All constructs were measured with validated scales, including The Working Alliance Inventory-Short Revised (WAI-SR) for therapeutic alliance, the Digital Working Alliance Inventory (DWAI) for digital alliance, the PROMIS Self-Efficacy for Managing Emotions Short Form scale for ER self-efficacy, and the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS) for co-morbid symptoms of depression and anxiety. RESULTS Significant reductions in co-morbid symptoms of depression and anxiety and significant increases in ER self-efficacy were found from baseline to treatment endpoint. Therapeutic and digital alliance at the midpoint each predicted reductions in co-morbid symptoms of depression and anxiety at the endpoint through ER self-efficacy, controlling for baseline scores. CONCLUSIONS Findings suggest that ER self-efficacy may be a proximal predictor of clinical improvement that may be enhanced by therapeutic and digital alliance. Future controlled research is essential to improve knowledge of the mechanisms of digital mental health interventions and to enhance their effectiveness.
Collapse
Affiliation(s)
- Natalia Macrynikola
- Division of Digital Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
| | - Sarah Chang
- Division of Digital Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
| | - John Torous
- Division of Digital Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
| |
Collapse
|
11
|
Eisenberg-Guyot J, Presskreischer R, Pamplin JR. Psychiatric Epidemiology During the COVID-19 Pandemic. CURR EPIDEMIOL REP 2024; 11:120-130. [PMID: 39803610 PMCID: PMC11720142 DOI: 10.1007/s40471-024-00342-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/08/2024] [Indexed: 01/16/2025]
Abstract
Purpose of review Our review critically examines research on trends in mental health among US adults following the COVID-19 pandemic's onset and makes recommendations for research on the topic. Recent findings Studies comparing pre-pandemic nationally representative government surveys ("benchmark surveys") with pandemic-era non-benchmark surveys generally estimated 3-4-fold increases in the prevalence of adverse mental-health outcomes following the pandemic's onset. However, studies analyzing trends in repeated waves of a single survey, which may carry a lower risk of bias, generally estimated much smaller increases in adverse outcomes. Likewise in our analysis of benchmark surveys, we estimated <1% increases in the prevalence of adverse outcomes from 2018/2019-2021. Finally, studies analyzing vital-statistics data estimated spiking fatal-overdose rates, but stable suicide rates. Summary Although fatal-overdose rates increased substantially following the pandemic's onset, evidence suggests the population prevalence of other adverse mental-health outcomes may have departed minimally from prior years' trends, at least through 2021. Future research on trends through the pandemic's later stages should prioritize leveraging repeated waves of benchmark surveys to minimize risk of bias.
Collapse
Affiliation(s)
- Jerzy Eisenberg-Guyot
- Department of Epidemiology, Mailman School of Public Health, Columbia University, NY, NY
| | - Rachel Presskreischer
- Department of Epidemiology, Mailman School of Public Health, Columbia University, NY, NY
| | - John R. Pamplin
- Department of Epidemiology, Mailman School of Public Health, Columbia University, NY, NY
| |
Collapse
|
12
|
Ratnapradipa KL, Houfek JF, Gearhart P, Schneider EO, Chasek C, Dinkel D, Cordts KM, Doyle M, Chaudhary P, Bhale D, Watanabe-Galloway S. Exploring the Dynamics of Attracting and Retaining Acute Care Psychiatric Registered Nurses: An In-Depth Analysis Using Focus Groups. J Nurs Manag 2024; 2024:3167255. [PMID: 40224896 PMCID: PMC11918850 DOI: 10.1155/2024/3167255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2024] [Revised: 04/01/2024] [Accepted: 04/02/2024] [Indexed: 04/15/2025]
Abstract
The recruitment and retention of in-patient psychiatric mental health registered nurses (PMH-RNs) remains a challenge. This qualitative study sought to identify factors impacting the recruitment and retention of PMH-RNs in acute-care settings. Participants (N = 15) were recruited for focus groups including one with in-patient unit administrators (n = 4), two with current PMH-RNs (n = 7), and two with nursing students (n = 4). Data were analyzed using a directed content analysis approach. Participants were informed about the study's purpose, procedures, potential risks, and benefits, and they provided verbal consent before participating. Administrators emphasized a focus on retention and described a variety of supports they provided PMH-RNs, including formal and informal support and education. PMH-RNs' most prevalent concerns were their safety, co-worker and/or management challenges, and emotional and/or physical exhaustion. Students also expressed concerns about safety in psychiatric settings and desired more interaction with PMH-RNs. They were also interested in learning more about the specialty as they valued the opportunity to see change in patients. All three groups mentioned a need for more interaction between students and PMH-RNs, while safety concerns were expressed by both PMH-RNs and students. Because PMH-RNs play a critical role for in-patient psychiatric care, recruiting and retaining specialist nurses can focus on increasing student engagement with the PMH-RNs, attending to PMH-RNs' management and staffing concerns, and providing additional resources for responding to events that threaten safety in the workplace to prevent burnout.
Collapse
Affiliation(s)
- Kendra L. Ratnapradipa
- Behavioral Health Education Center of Nebraska (BHECN), University of Nebraska Medical Center, 984242 NE Medical Center, Omaha, NE 68198-4242, USA
- Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, 984395 Nebraska Medical Center, Omaha, NE 68198-4395, USA
| | - Julia F. Houfek
- College of Nursing, University of Nebraska Medical Center, 985470 Nebraska Medical Center, Omaha, NE 68198-5470, USA
| | - Phoebe Gearhart
- Department of Psychiatry, Nebraska Medicine, Omaha, NE 68198-5578, USA
| | - Erin O. Schneider
- Behavioral Health Education Center of Nebraska (BHECN), University of Nebraska Medical Center, 984242 NE Medical Center, Omaha, NE 68198-4242, USA
| | - Christine Chasek
- Behavioral Health Education Center of Nebraska (BHECN), University of Nebraska Medical Center, 984242 NE Medical Center, Omaha, NE 68198-4242, USA
- Department of Counseling, College of Education, Health & Human Sciences, University of Nebraska Omaha, Omaha, NE 68182, USA
| | - Danae Dinkel
- School of Health and Kinesiology, University of Nebraska Omaha, Omaha, NE 68182, USA
| | - Katrina M. Cordts
- Behavioral Health Education Center of Nebraska (BHECN), University of Nebraska Medical Center, 984242 NE Medical Center, Omaha, NE 68198-4242, USA
- Department of Neurological Sciences, College of Medicine, University of Nebraska Medical Center, 985920 Nebraska Medical Center, Omaha, NE 68198-5920, USA
| | - Marley Doyle
- Behavioral Health Education Center of Nebraska (BHECN), University of Nebraska Medical Center, 984242 NE Medical Center, Omaha, NE 68198-4242, USA
- Department of Psychiatry, College of Medicine, University of Nebraska Medical Center, 985575 Nebraska Medical Center, Omaha, NE 68198-5575, USA
| | - Priyanka Chaudhary
- School of Health and Kinesiology, University of Nebraska Omaha, Omaha, NE 68182, USA
| | - Deepanjali Bhale
- Behavioral Health Education Center of Nebraska (BHECN), University of Nebraska Medical Center, 984242 NE Medical Center, Omaha, NE 68198-4242, USA
| | - Shinobu Watanabe-Galloway
- Behavioral Health Education Center of Nebraska (BHECN), University of Nebraska Medical Center, 984242 NE Medical Center, Omaha, NE 68198-4242, USA
- Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, 984395 Nebraska Medical Center, Omaha, NE 68198-4395, USA
| |
Collapse
|
13
|
Perry BL, Smith NC, Coleman ME, Pescosolido BA. Social Networks, the COVID-19 Pandemic, and Emerging Adults' Mental Health: Resiliency Through Social Bonding and Cohesion. Am J Public Health 2024; 114:S258-S267. [PMID: 37948054 PMCID: PMC10976447 DOI: 10.2105/ajph.2023.307426] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/14/2023] [Indexed: 11/12/2023]
Abstract
Objectives. To assess how personal social network characteristics moderated mental health declines during the COVID-19 pandemic in emerging adults compared with other age groups. Methods. The Person to Person Health Interview Study, a representative, probability-based cohort study (n = 2485) in Indiana, collected data through face-to-face (baseline) and phone (follow-up) interviews before and during the pandemic. We used survey-weighted growth curve models to examine network effects on computer-adaptive testing measures of depression and anxiety severity. Results. Respondents reported significantly increased depression and anxiety in 2021, which returned almost to baseline levels for most age groups by 2022 (P < .001). Stronger ties to others and more interconnected ties were significantly associated with lower depression (B = -0.112 [P < .05]; B = -0.086 [P < .001]) and anxiety (B = -0.101 [P < .05]; B = -0.063 [P < .01]) severity across the pandemic. Interaction models revealed disproportionate protective effects of network characteristics on depression (B = -0.456 [P < .001]; B = -0.268 [P < .001]) and anxiety (B = -0.388 [P < .001]; B = -0.284 [P < .001]) for emerging adults. Conclusions. Cohesive and affectively strong personal networks promote resiliency to common mental health challenges during periods of crisis, particularly for emerging adults whose social roles and relationships were disrupted during a critical period of development. (Am J Public Health. 2024;114(S3):S258-S267. https://doi.org/10.2105/AJPH.2023.307426).
Collapse
Affiliation(s)
- Brea L Perry
- Brea L. Perry and Bernice A. Pescosolido are with the Department of Sociology and the Irsay Institute for Sociomedical Sciences Research, Indiana University, Bloomington, IN. Nicholas C. Smith and Max E. Coleman were with the Department of Sociology, Indiana University, Bloomington, during preparation of the article
| | - Nicholas C Smith
- Brea L. Perry and Bernice A. Pescosolido are with the Department of Sociology and the Irsay Institute for Sociomedical Sciences Research, Indiana University, Bloomington, IN. Nicholas C. Smith and Max E. Coleman were with the Department of Sociology, Indiana University, Bloomington, during preparation of the article
| | - Max E Coleman
- Brea L. Perry and Bernice A. Pescosolido are with the Department of Sociology and the Irsay Institute for Sociomedical Sciences Research, Indiana University, Bloomington, IN. Nicholas C. Smith and Max E. Coleman were with the Department of Sociology, Indiana University, Bloomington, during preparation of the article
| | - Bernice A Pescosolido
- Brea L. Perry and Bernice A. Pescosolido are with the Department of Sociology and the Irsay Institute for Sociomedical Sciences Research, Indiana University, Bloomington, IN. Nicholas C. Smith and Max E. Coleman were with the Department of Sociology, Indiana University, Bloomington, during preparation of the article
| |
Collapse
|
14
|
Cozen AE, Carton T, Hamad R, Kornak J, Faulkner Modrow M, Peyser ND, Park S, Orozco JH, Brandner M, O’Brien EC, Djibo DA, McMahill-Walraven CN, Isasi CR, Beatty AL, Olgin JE, Marcus GM, Pletcher MJ. Factors associated with anxiety during the first two years of the COVID-19 pandemic in the United States: An analysis of the COVID-19 Citizen Science study. PLoS One 2024; 19:e0297922. [PMID: 38319951 PMCID: PMC10846720 DOI: 10.1371/journal.pone.0297922] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2023] [Accepted: 01/15/2024] [Indexed: 02/08/2024] Open
Abstract
COVID-19 increased the prevalence of clinically significant anxiety in the United States. To investigate contributing factors we analyzed anxiety, reported online via monthly Generalized Anxiety Disorders-7 (GAD-7) surveys between April 2020 and May 2022, in association with self-reported worry about the health effects of COVID-19, economic difficulty, personal COVID-19 experience, and subjective social status. 333,292 anxiety surveys from 50,172 participants (82% non-Hispanic white; 73% female; median age 55, IQR 42-66) showed high levels of anxiety, especially early in the pandemic. Anxiety scores showed strong independent associations with worry about the health effects of COVID-19 for oneself or family members (GAD-7 score +3.28 for highest vs. lowest category; 95% confidence interval: 3.24, 3.33; p<0.0001 for trend) and with difficulty paying for basic living expenses (+2.06; 1.97, 2.15, p<0.0001) in multivariable regression models after adjusting for demographic characteristics, COVID-19 case rates and death rates, and personal COVID-19 experience. High levels of COVID-19 health worry and economic stress were each more common among participants reporting lower subjective social status, and median anxiety scores for those experiencing both were in the range considered indicative of moderate to severe clinical anxiety disorders. In summary, health worry and economic difficulty both contributed to high rates of anxiety during the first two years of the COVID-19 pandemic in the US, especially in disadvantaged socioeconomic groups. Programs to address both health concerns and economic insecurity in vulnerable populations could help mitigate pandemic impacts on anxiety and mental health.
Collapse
Affiliation(s)
- Aaron E. Cozen
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America
| | - Thomas Carton
- Louisiana Public Health Institute, New Orleans, LA, United States of America
| | - Rita Hamad
- Dept of Social and Behavioral Sciences, Harvard School of Public Health, Boston, MA, United States of America
| | - John Kornak
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America
| | - Madelaine Faulkner Modrow
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America
| | - Noah D. Peyser
- Division of Cardiology, University of California, San Francisco, San Francisco, CA, United States of America
| | - Soo Park
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America
| | - Jaime H. Orozco
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America
| | - Matthew Brandner
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America
- Department of Family and Community Medicine, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA, United States of America
| | - Emily C. O’Brien
- Duke Clinical Research Institute, Durham, NC, United States of America
| | | | | | - Carmen R. Isasi
- Department of Epidemiology, Albert Einstein College of Medicine, The Bronx, NY, United States of America
| | - Alexis L. Beatty
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America
- Division of Cardiology, University of California, San Francisco, San Francisco, CA, United States of America
| | - Jeffrey E. Olgin
- Division of Cardiology, University of California, San Francisco, San Francisco, CA, United States of America
| | - Gregory M. Marcus
- Division of Cardiology, University of California, San Francisco, San Francisco, CA, United States of America
| | - Mark J. Pletcher
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America
| |
Collapse
|
15
|
Nichols E, Petrosyan S, Khobragade P, Banerjee J, Angrisani M, Dey S, Bloom DE, Schaner S, Dey AB, Lee J. Trajectories and correlates of poor mental health in India over the course of the COVID-19 pandemic: a nationwide survey. BMJ Glob Health 2024; 9:e013365. [PMID: 38286516 PMCID: PMC10826618 DOI: 10.1136/bmjgh-2023-013365] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2023] [Accepted: 12/20/2023] [Indexed: 01/31/2024] Open
Abstract
INTRODUCTION The COVID-19 pandemic had large impacts on mental health; however, most existing evidence is focused on the initial lockdown period and high-income contexts. By assessing trajectories of mental health symptoms in India over 2 years, we aim to understand the effect of later time periods and pandemic characteristics on mental health in a lower-middle income context. METHODS We used data from the Real-Time Insights of COVID-19 in India cohort study (N=3709). We used covariate-adjusted linear regression models with generalised estimating equations to assess associations between mental health (Patient Health Questionnaire (PHQ-4) score; range 0-12) and pandemic periods as well as pandemic characteristics (COVID-19 cases and deaths, government stringency, self-reported financial impact, COVID-19 infection in the household) and explored effect modification by age, gender and rural/urban residence. RESULTS Mental health symptoms dropped immediately following the lockdown period but rose again during the delta and omicron waves. Associations between mental health and later pandemic stages were stronger for adults 45 years of age and older (p<0.001). PHQ-4 scores were significantly associated with all pandemic characteristics considered, including estimated COVID-19 deaths (PHQ-4 difference of 0.10 units; 95% CI 0.06 to 0.13), government stringency index (0.14 units; 95% CI 0.11 to 0.18), self-reported major financial impacts (1.20 units; 95% CI 1.09 to 1.32) and COVID-19 infection in the household (0.36 units; 95% CI 0.23 to 0.50). CONCLUSION While the lockdown period and associated financial stress had the largest mental health impacts on Indian adults, the effects of the pandemic on mental health persisted over time, especially among middle-aged and older adults. Results highlight the importance of investments in mental health supports and services to address the consequences of cyclical waves of infections and disease burden due to COVID-19 or other emerging pandemics.
Collapse
Affiliation(s)
- Emma Nichols
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
| | - Sarah Petrosyan
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
| | - Pranali Khobragade
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
| | - Joyita Banerjee
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
| | - Marco Angrisani
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
- Department of Economics, University of Southern California, Los Angeles, California, USA
| | - Sharmistha Dey
- All India Institute of Medical Sciences, New Delhi, India
| | - David E Bloom
- Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA
| | - Simone Schaner
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
- Department of Economics, University of Southern California, Los Angeles, California, USA
| | - Aparajit B Dey
- Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Jinkook Lee
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA
- Department of Economics, University of Southern California, Los Angeles, California, USA
| |
Collapse
|
16
|
Bacchi P, Suen P, Fatori D, Razza LB, Afonso L, Klein I, Cavendish B, Moreno ML, Santos IS, Benseñor I, Lotufo P, Brunoni AR. Incidence of suicidal ideation in a cohort of civil servants during the COVID-19 pandemic in Brazil: insights from the ELSA-Brasil Study. TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY 2024; 46:e20230701. [PMID: 38183668 PMCID: PMC11565249 DOI: 10.47626/2237-6089-2023-0701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Accepted: 11/22/2023] [Indexed: 01/08/2024]
Abstract
OBJECTIVE This study investigated the incidence of suicidal ideation and its associated risk factors in the state of São Paulo in the Brazilian Longitudinal Study of Adult Health (Estudo Longitudinal de Saúde do Adulto [ELSA-Brasil]) cohort during the coronavirus disease 2019 (COVID-19) pandemic. METHODS In a pre-pandemic ELSA-Brasil onsite assessment in 2016-2018 (wave 3) and a pandemic online assessment in May-July 2020 (wave COVID), we assessed suicidal ideation using the Clinical Interview Schedule-Revised (CIS-R). Single and multi predictor logistic regressions were performed using sociodemographic characteristics, household financial impact during the pandemic, presence of previous chronic diseases, alcohol abuse, adverse childhood experiences (ACE), living alone, and previous common mental disorders (CMD) as predictors. Incidence of suicidal ideation was used as outcome. RESULTS Out of 4,191 participants in wave 3, 2,117 (50.5%) also answered the COVID wave. There was a threefold increase in suicide ideation, from 34 (1.8%) to 104 (5.6%) participants. In multiple predictor models, we found that previous CMD (odds ratio [OR] 7.17; 95% confidence interval [95%CI] 4.43 - 11.58) and ACE (OR 1.72; 95%CI 1.09 - 2.72) increased the odds of incident suicidal ideation. The sociodemographic predictors female sex, younger age, and low income were significant risk factors in the single predictor models only. CONCLUSIONS These findings underscore the importance of monitoring and supporting individuals who suffered ACE and have a history of mental health disorders. This is especially critical in times of heightened societal stress, such as the COVID-19 pandemic.
Collapse
Affiliation(s)
- Pedro Bacchi
- Laboratório de Neurociências (LIM-27), Departamento de Psiquiatria, Instituto de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil
| | - Paulo Suen
- Laboratório de Neurociências (LIM-27), Departamento de Psiquiatria, Instituto de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil. Faculdade de Medicina, USP, São Paulo, SP, Brazil
| | | | - Lais B Razza
- Laboratório de Neurociências (LIM-27), Departamento de Psiquiatria, Instituto de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil. Departamento de Clínica Médica, Faculdade de Medicina, USP, São Paulo, SP, Brazil
| | - Leonardo Afonso
- Laboratório de Neurociências (LIM-27), Departamento de Psiquiatria, Instituto de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo SP, Brazil
| | - Izio Klein
- Laboratório de Neurociências (LIM-27), Departamento de Psiquiatria, Instituto de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil
| | - Beatriz Cavendish
- Laboratório de Neurociências (LIM-27), Departamento de Psiquiatria, Instituto de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil
| | - Marina L Moreno
- Faculdade de Medicina, USP, São Paulo, SP, Brazil. Departamento de Clínica Médica, Faculdade de Medicina, USP, São Paulo, SP, Brazil. Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, USP, São Paulo, SP, Brazil
| | - Itamar S Santos
- Faculdade de Medicina, USP, São Paulo, SP, Brazil. Departamento de Clínica Médica, Faculdade de Medicina, USP, São Paulo, SP, Brazil. Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, USP, São Paulo, SP, Brazil
| | - Isabela Benseñor
- Faculdade de Medicina, USP, São Paulo, SP, Brazil. Departamento de Clínica Médica, Faculdade de Medicina, USP, São Paulo, SP, Brazil. Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, USP, São Paulo, SP, Brazil
| | - Paulo Lotufo
- Faculdade de Medicina, USP, São Paulo, SP, Brazil. Departamento de Clínica Médica, Faculdade de Medicina, USP, São Paulo, SP, Brazil. Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, USP, São Paulo, SP, Brazil
| | - André R Brunoni
- Laboratório de Neurociências (LIM-27), Departamento de Psiquiatria, Instituto de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil. Faculdade de Medicina, USP, São Paulo, SP, Brazil. Departamento de Clínica Médica, Faculdade de Medicina, USP, São Paulo, SP, Brazil. Centro de Pesquisas Clínicas e Epidemiológicas, Hospital Universitário, USP, São Paulo, SP, Brazil
| |
Collapse
|
17
|
Lakra V. Has Psychiatry Drifted Away from Its Core Business? Indian J Psychol Med 2024; 46:1-4. [PMID: 38524950 PMCID: PMC10958075 DOI: 10.1177/02537176241231068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/26/2024] Open
Affiliation(s)
- Vinay Lakra
- The University of Melbourne, Parkville VIC, Australia
| |
Collapse
|
18
|
Rojas Cabrera JM, Oesterle TS, Rusheen AE, Goyal A, Scheitler KM, Mandybur I, Blaha CD, Bennet KE, Heien ML, Jang DP, Lee KH, Oh Y, Shin H. Techniques for Measurement of Serotonin: Implications in Neuropsychiatric Disorders and Advances in Absolute Value Recording Methods. ACS Chem Neurosci 2023; 14:4264-4273. [PMID: 38019166 PMCID: PMC10739614 DOI: 10.1021/acschemneuro.3c00618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 11/10/2023] [Accepted: 11/14/2023] [Indexed: 11/30/2023] Open
Abstract
Serotonin (5-HT) is a monoamine neurotransmitter in the peripheral, enteric, and central nervous systems (CNS). Within the CNS, serotonin is principally involved in mood regulation and reward-seeking behaviors. It is a critical regulator in CNS pathologies such as major depressive disorder, addiction, and schizophrenia. Consequently, in vivo serotonin measurements within the CNS have emerged as one of many promising approaches to investigating the pathogenesis, progression, and treatment of these and other neuropsychiatric conditions. These techniques vary in methods, ranging from analyte sampling with microdialysis to voltammetry. Provided this diversity in approach, inherent differences between techniques are inevitable. These include biosensor size, temporal/spatial resolution, and absolute value measurement capabilities, all of which must be considered to fit the prospective researcher's needs. In this review, we summarize currently available methods for the measurement of serotonin, including novel voltammetric absolute value measurement techniques. We also detail serotonin's role in various neuropsychiatric conditions, highlighting the role of phasic and tonic serotonergic neuronal firing within each where relevant. Lastly, we briefly review the present clinical application of these techniques and discuss the potential of a closed-loop monitoring and neuromodulation system utilizing deep brain stimulation (DBS).
Collapse
Affiliation(s)
- Juan M. Rojas Cabrera
- Medical
Scientist Training Program, Mayo Clinic, Rochester, Minnesota 55902, United States
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Tyler S. Oesterle
- Department
of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55902, United States
- Robert
D. and Patricia K. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Aaron E. Rusheen
- Medical
Scientist Training Program, Mayo Clinic, Rochester, Minnesota 55902, United States
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Abhinav Goyal
- Medical
Scientist Training Program, Mayo Clinic, Rochester, Minnesota 55902, United States
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Kristen M. Scheitler
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Ian Mandybur
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Charles D. Blaha
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Kevin E. Bennet
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
- Division
of Engineering, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Michael L. Heien
- Department
of Chemistry and Biochemistry, University
of Arizona, Tucson, Arizona 85721, United States
| | - Dong Pyo Jang
- Department
of Biomedical Engineering, Hanyang University, Seoul 04763, South Korea
| | - Kendall H. Lee
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
- Department
of Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Yoonbae Oh
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
- Department
of Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55902, United States
| | - Hojin Shin
- Department
of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55902, United States
- Department
of Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55902, United States
| |
Collapse
|
19
|
Wagner B, Snoubar Y, Mahdi YS. Access and efficacy of university mental health services during the COVID-19 pandemic. Front Public Health 2023; 11:1269010. [PMID: 38174076 PMCID: PMC10761424 DOI: 10.3389/fpubh.2023.1269010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 11/21/2023] [Indexed: 01/05/2024] Open
Abstract
Objective This study sought to understand the mental health issues, mental health support and efficacy of that support among university students. Participants All students enrolled in a College of Arts and Sciences at one mid-size university received an email that contained a link to an anonymous, online questionnaire developed and disseminated through PsychData. 162 students completed the questionnaire. Methods Mixed methods: Data was summarized using descriptive analysis, testing for significance, testing for differences, and content analysis. Results Participants reported high levels of anxiety (76%) and depression (65%). Results indicated that participant demographics were associated with types of mental access, and support. Unexpected results included lack of knowledge or information on cost, and how to access mental health services hindered access for participants, and although telehealth was the most widely used support, in contrast to other studies, participants indicated a preference for face-to-face mental health services. Conclusion Results highlight the need for improving communication about and access to mental health services in higher education Recommendations and implications for policy and support services are provided.
Collapse
Affiliation(s)
- Beverly Wagner
- Social Work Department, Texas Woman's University, Denton, TX, United States
| | - Yaser Snoubar
- Social Sciences Department, Qatar University, Doha, Qatar
| | | |
Collapse
|
20
|
van der Velden PG, Contino C, de Vroege L, Das M, Bosmans M, Zijlmans J. The prevalence of anxiety and depression symptoms (ADS), persistent and chronic ADS among the adult general population and specific subgroups before and during the COVID-19 pandemic until December 2021. J Affect Disord 2023; 338:393-401. [PMID: 37364654 PMCID: PMC10290740 DOI: 10.1016/j.jad.2023.06.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/11/2022] [Revised: 05/28/2023] [Accepted: 06/20/2023] [Indexed: 06/28/2023]
Abstract
BACKGROUND It is unclear to what extent the prevalence of moderate and severe anxiety and depression symptoms (ADS) is higher during the first 20 months after the COVID-19 outbreak than before the outbreak. The same holds for persistent and chronic ADS among the adult general population and subgroups (such as employed, minorities, young adults, work disabled). METHODS Data were extracted from six surveys conducted with the Dutch longitudinal LISS panel, based on a traditional probability sample (N = 3493). Biographic characteristics and ADS (MHI-5 scores) were assessed in March-April 2019, November-December 2019, March-April 2020, November-December 2020, March-April 2021, and November-December 2021. Generalized estimating equations were conducted to examine differences in the prevalence of post-outbreak ADS, persistent and chronic ADS compared to the pre-outbreak prevalence in similar periods. The Benjamini-Hochberg correction for multiple testing was applied. RESULTS Among the general population chronic moderate ADS increased significantly but slightly in the period March-April 2020 to March-April 2021 compared to a similar period before the pandemic (11.9 % versus 10.9 %, Odds Ratio = 1.11). In the same period a somewhat larger significant increase in chronic moderate ADS was observed among 19-24 years old respondents (21.4 % versus 16.7 %, Odds Ratio = 1.35). After the Benjamini-Hochberg correction several other differences were no longer significant. LIMITATIONS No other mental health problems were assessed. CONCLUSIONS The Dutch general population and most of the assessed subgroups were relatively resilient given the limited increase or absence of increases in (persistent and chronic) ADS. However, young adults suffered from an increase of chronic ADS.
Collapse
Affiliation(s)
- Peter G van der Velden
- Centerdata, Tilburg, the Netherlands; TRANZO, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, the Netherlands.
| | | | - Lars de Vroege
- TRANZO, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, the Netherlands; GGz Breburg, Breda, the Netherlands
| | - Marcel Das
- Centerdata, Tilburg, the Netherlands; Tilburg School of Economics and Management, Tilburg University, Tilburg, the Netherlands
| | | | - Josjan Zijlmans
- Amsterdam University Medical Centres, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands; Department of Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| |
Collapse
|
21
|
Hintz AM, Gomes-Filho IS, Loomer PM, de Sousa Pinho P, de Santana Passos-Soares J, Trindade SC, Cerqueira EDMM, Alves CMC, Rios YSS, Batista JET, Figueiredo ACMG, Cruz SSD. Depression and associated factors among Brazilian adults: the 2019 national healthcare population-based study. BMC Psychiatry 2023; 23:704. [PMID: 37770824 PMCID: PMC10537974 DOI: 10.1186/s12888-023-05133-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/24/2022] [Accepted: 08/23/2023] [Indexed: 09/30/2023] Open
Abstract
BACKGROUND Mental disorders represent a major public health challenge worldwide, affecting 80% of people living in low- and middle-income countries. Depression, a mental disorder, is a chronic disease of long duration that causes changes in the brain, resulting from a combination of genetic, physiologic, environmental, and behavioral factors. The aim of this study was to investigate possible factors associated with depression in Brazilian adults. METHODS A population-based, cross-sectional study was carried out using the public domain database of the 2019 National Health Survey, conducted in Brazil. Depression was considered the dependent variable, and through hierarchical analysis, predictor variables were investigated such as, at the distal level-socioeconomic variables, at the intermediate level-variables related to lifestyle behavior, health condition, and history, and at the proximal level-demographic variables. Logistic regression analysis was used to obtain the adjusted Odds Ratio and the respective 95% confidence interval to identify possible factors associated with depression. RESULTS The study included 88,531 participant records with 10.27% diagnosed with depression. The adjusted association measurements, after selecting the independent variables in the hierarchical analysis, showed the following factors associated with depression with differing magnitudes: age, brown and white race/skin color, female sex, poor, very poor, or regular self-reported health condition, diagnosis of cardiovascular disease, work-related musculoskeletal disorder, history of smoking habit, and macroeconomic region. CONCLUSIONS An effective strategy for preventing and managing depression in Brazilian adults must include the control of health status and lifestyle behavior factors, with actions and programs to reduce people's exposure to these factors, understanding that socioeconomic-demographic differences of each population can potentially reduce the disease burden.
Collapse
Affiliation(s)
| | | | - Peter Michael Loomer
- School of Dentistry, University of Texas Health Science Center, San Antonio, TX, USA
| | - Paloma de Sousa Pinho
- Health Sciences Center, Federal University of Recôncavo of Bahia, Santo Antonio de Jesus, Bahia, Brazil
| | - Johelle de Santana Passos-Soares
- Department of Health, Feira de Santana State University, Feira de Santana, Bahia, Brazil
- Department of Preventive Dentistry, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Soraya Castro Trindade
- Department of Health, Feira de Santana State University, Feira de Santana, Bahia, Brazil
| | | | | | | | | | | | - Simone Seixas da Cruz
- Department of Health, Feira de Santana State University, Feira de Santana, Bahia, Brazil
- Health Sciences Center, Federal University of Recôncavo of Bahia, Santo Antonio de Jesus, Bahia, Brazil
| |
Collapse
|
22
|
Nichols E, Petrosyan S, Khobragade P, Banerjee J, Angrisani M, Dey S, Bloom DE, Schaner S, Dey AB, Lee J. Trajectories and correlates of poor mental health in India over the course of the COVID-19 pandemic: a nation-wide survey. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2023:2023.09.13.23295513. [PMID: 37745425 PMCID: PMC10516061 DOI: 10.1101/2023.09.13.23295513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/26/2023]
Abstract
Introduction The COVID-19 pandemic had large impacts on mental health; however, most existing evidence is focused on the initial lockdown period and high-income contexts. By assessing trajectories of mental health symptoms in India over two years, we aim to understand the effect of later time periods and pandemic characteristics on mental health in a lower-middle income context. Methods We used data from the Real-Time Insights of COVID-19 in India (RTI COVID-India) cohort study (N=3,662). We used covariate-adjusted linear regression models with generalized estimating equations to assess associations between mental health (PHQ-4 score) and pandemic periods as well as pandemic characteristics (COVID-19 cases and deaths, government stringency, self-reported financial impact, COVID-19 infection in the household) and explored effect modification by age, gender, and rural/urban residence. Results Mental health symptoms dropped immediately following the lockdown period but rose again during the delta and omicron waves. Associations between mental health and later pandemic stages were stronger for adults 45 years of age and older (p<0.001). PHQ-4 scores were significantly and independently associated with all pandemic characteristics considered, including estimated COVID-19 deaths (PHQ-4 difference of 0.041 SD units; 95% Confidence Interval 0.030 - 0.053), government stringency index (0.060 SD units; 0.048 - 0.072), self-reported major financial impacts (0.45 SD units; 0.41-0.49), and COVID-19 infection in the household (0.11 SD units; 0.07-0.16). Conclusion While the lockdown period and associated financial stress had the largest mental health impacts on Indian adults, the effects of the pandemic on mental health persisted over time, especially among middle-age and older adults. Results highlight the importance of investments in mental health supports and services to address the consequences of cyclical waves of infections and disease burden due to COVID-19 or other emerging pandemics.
Collapse
Affiliation(s)
- Emma Nichols
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Sarah Petrosyan
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Pranali Khobragade
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Joyita Banerjee
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
| | - Marco Angrisani
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
- Department of Economics, University of Southern California, Los Angeles, CA, USA
| | - Sharmistha Dey
- All India Institute of Medical Sciences, New Delhi, India
| | - David E. Bloom
- Harvard School of Public Health, Boston, Massachusetts, USA
| | - Simone Schaner
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
- Department of Economics, University of Southern California, Los Angeles, CA, USA
| | - AB Dey
- Venu Geriatric Institute, New Delhi, India
| | - Jinkook Lee
- Center for Economic and Social Research, University of Southern California, Los Angeles, CA, USA
- Department of Economics, University of Southern California, Los Angeles, CA, USA
| |
Collapse
|
23
|
Perlis RH, Lunz Trujillo K, Safarpour A, Quintana A, Simonson MD, Perlis J, Santillana M, Ognyanova K, Baum MA, Druckman JN, Lazer D. Community Mobility and Depressive Symptoms During the COVID-19 Pandemic in the United States. JAMA Netw Open 2023; 6:e2334945. [PMID: 37755830 PMCID: PMC10534266 DOI: 10.1001/jamanetworkopen.2023.34945] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Accepted: 08/09/2023] [Indexed: 09/28/2023] Open
Abstract
Importance Marked elevation in levels of depressive symptoms compared with historical norms have been described during the COVID-19 pandemic, and understanding the extent to which these are associated with diminished in-person social interaction could inform public health planning for future pandemics or other disasters. Objective To describe the association between living in a US county with diminished mobility during the COVID-19 pandemic and self-reported depressive symptoms, while accounting for potential local and state-level confounding factors. Design, Setting, and Participants This survey study used 18 waves of a nonprobability internet survey conducted in the United States between May 2020 and April 2022. Participants included respondents who were 18 years and older and lived in 1 of the 50 US states or Washington DC. Main Outcome and Measure Depressive symptoms measured by the Patient Health Questionnaire-9 (PHQ-9); county-level community mobility estimates from mobile apps; COVID-19 policies at the US state level from the Oxford stringency index. Results The 192 271 survey respondents had a mean (SD) of age 43.1 (16.5) years, and 768 (0.4%) were American Indian or Alaska Native individuals, 11 448 (6.0%) were Asian individuals, 20 277 (10.5%) were Black individuals, 15 036 (7.8%) were Hispanic individuals, 1975 (1.0%) were Pacific Islander individuals, 138 702 (72.1%) were White individuals, and 4065 (2.1%) were individuals of another race. Additionally, 126 381 respondents (65.7%) identified as female and 65 890 (34.3%) as male. Mean (SD) depression severity by PHQ-9 was 7.2 (6.8). In a mixed-effects linear regression model, the mean county-level proportion of individuals not leaving home was associated with a greater level of depression symptoms (β, 2.58; 95% CI, 1.57-3.58) after adjustment for individual sociodemographic features. Results were similar after the inclusion in regression models of local COVID-19 activity, weather, and county-level economic features, and persisted after widespread availability of COVID-19 vaccination. They were attenuated by the inclusion of state-level pandemic restrictions. Two restrictions, mandatory mask-wearing in public (β, 0.23; 95% CI, 0.15-0.30) and policies cancelling public events (β, 0.37; 95% CI, 0.22-0.51), demonstrated modest independent associations with depressive symptom severity. Conclusions and Relevance In this study, depressive symptoms were greater in locales and times with diminished community mobility. Strategies to understand the potential public health consequences of pandemic responses are needed.
Collapse
Affiliation(s)
- Roy H. Perlis
- Massachusetts General Hospital, Boston
- Harvard Medical School, Boston, Massachusetts
| | - Kristin Lunz Trujillo
- Northeastern University, Boston, Massachusetts
- Harvard University, Cambridge, Massachusetts
| | - Alauna Safarpour
- Northeastern University, Boston, Massachusetts
- Harvard University, Cambridge, Massachusetts
| | - Alexi Quintana
- Northeastern University, Boston, Massachusetts
- Harvard University, Cambridge, Massachusetts
| | | | | | | | | | | | | | - David Lazer
- Northeastern University, Boston, Massachusetts
| |
Collapse
|
24
|
Gilbert PA, Soweid L, Holdefer PJ, Kersten S, Mulia N. Strategies to maintain recovery from alcohol problems during the COVID-19 pandemic: Insights from a mixed-methods national survey of adults in the United States. PLoS One 2023; 18:e0284435. [PMID: 37068066 PMCID: PMC10109499 DOI: 10.1371/journal.pone.0284435] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2022] [Accepted: 04/01/2023] [Indexed: 04/18/2023] Open
Abstract
The COVID-19 pandemic has been associated with poorer mental health and, in some cases, increased alcohol consumption; however, little is known about the pandemic's effects on people in recovery from alcohol use disorder (AUD), especially how they have coped with novel stressors. Our mixed-methods study investigated strategies used to maintain recovery during the pandemic, with attention to variation by gender. We analyzed data obtained in fall 2020 from an online US national survey of adults with resolved AUD (n = 1,492) recruited from KnowledgePanel, a probability-based cohort of non-institutionalized adults maintained by Ipsos for internet-based research. Participants endorsed possible coping strategies on a 19-item choose-all-that-apply list, which were analyzed using chi-square tests. In addition, 1,008 participants provided text responses to an open-ended question about their strategies to maintain recovery during the pandemic, which were coded and analyzed using an inductive, thematic approach. The majority of our sample met criteria for severe lifetime AUD (72.9%), reported being in recovery more than five years (75.5%), and had never used specialty AUD services or mutual-help groups (59.7%). The ordering of the coping strategies was quite similar for women and men; however, the top strategy (talking with family and friends by phone, text, or video) was endorsed more frequently by women than men (49.7% vs. 36.1%; p < .001). Among qualitative themes, "staying connected" was the most common. It was dominated by statements about family, with women mentioning children more often than men. Among other themes, "cognitive strategies" mirrored established therapeutic modalities, and "active pursuits" aligned with many recent recommendations for service providers working with substance-using populations during the pandemic. A minority of participants invoked "willpower" for recovery or stated that pandemic restrictions helped by reducing exposure to relapse risks. These findings shed light on recovery mechanisms during the COVID-19 pandemic and suggest potential intervention targets to support recovery during other catastrophic events, such as natural disasters.
Collapse
Affiliation(s)
- Paul A. Gilbert
- Department of Community and Behavioral Health, University of Iowa, Iowa City, Iowa, United States of America
| | - Loulwa Soweid
- Department of Community and Behavioral Health, University of Iowa, Iowa City, Iowa, United States of America
| | - Paul J. Holdefer
- Department of Community and Behavioral Health, University of Iowa, Iowa City, Iowa, United States of America
| | - Sarah Kersten
- Department of Community and Behavioral Health, University of Iowa, Iowa City, Iowa, United States of America
| | - Nina Mulia
- Alcohol Research Group, Public Health Institute, Emeryville, California, Unites States of America
| |
Collapse
|
25
|
Mulia N, Ye Y, Greenfield TK, Martinez P, Patterson D, Kerr WC, Karriker-Jaffe KJ. Inequitable access to general and behavioral healthcare in the US during the COVID-19 pandemic: A role for telehealth? Prev Med 2023; 169:107426. [PMID: 36709864 PMCID: PMC9877144 DOI: 10.1016/j.ypmed.2023.107426] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2022] [Revised: 01/17/2023] [Accepted: 01/19/2023] [Indexed: 01/27/2023]
Abstract
Wide-ranging effects of the COVID-19 pandemic have led to increased psychological distress and alcohol consumption, and disproportionate hardship for disadvantaged groups. Early in the pandemic, telehealth services were expanded to maintain healthcare access amidst lockdowns, medical office closures, and fear of infection. This study examines general and behavioral healthcare access and disparities during the first year of the pandemic. Data are from the 2019-2020 US National Alcohol Survey (collected February 2019 to April 2020) and its COVID follow-up survey conducted January 30 to March 28, 2021 (N = 1819). General and behavioral healthcare-related outcomes were assessed at follow-up, and included perceived need for and receipt of care, delayed care, and use of telehealth since April 1, 2020. Results indicate that the majority of respondents with perceived need for healthcare received some behavioral healthcare (reported by 63%) and particularly general healthcare (88%), but nearly half (48%) delayed needed care. Delays were mostly due to COVID-related reasons, but cost barriers also were common and significantly impeded care-seeking by uninsured persons, young adults, rural residents, and persons whose employment was reduced by the pandemic. Disparities in the receipt of healthcare were pronounced for Hispanic/Latinx (vs. White) and lower-income (vs. higher-income) groups (AORs <0.37, p's < 0.05). Notably, telehealth was commonly used by Hispanic/Latinx and lower-income groups for general and particularly behavioral healthcare. Results suggest that telehealth has provided an important bridge to healthcare for certain medically underserved groups during the pandemic, and may be vital to future efforts to increase equity in healthcare access.
Collapse
Affiliation(s)
- Nina Mulia
- Alcohol Research Group, 6001 Shellmound St., Suite 450, Emeryville, CA 94608, USA.
| | - Yu Ye
- Alcohol Research Group, 6001 Shellmound St., Suite 450, Emeryville, CA 94608, USA
| | - Thomas K Greenfield
- Alcohol Research Group, 6001 Shellmound St., Suite 450, Emeryville, CA 94608, USA
| | - Priscilla Martinez
- Alcohol Research Group, 6001 Shellmound St., Suite 450, Emeryville, CA 94608, USA
| | - Deidre Patterson
- Alcohol Research Group, 6001 Shellmound St., Suite 450, Emeryville, CA 94608, USA
| | - William C Kerr
- Alcohol Research Group, 6001 Shellmound St., Suite 450, Emeryville, CA 94608, USA
| | | |
Collapse
|
26
|
Cowden RG, Nakamura JS, de la Rosa Fernández Pacheco PA, Chen Y, Fulks J, Plake JF, VanderWeele TJ. The road to postpandemic recovery in the USA: a repeated cross-sectional survey of multidimensional well-being over two years. Public Health 2023; 217:212-217. [PMID: 36924673 PMCID: PMC10010931 DOI: 10.1016/j.puhe.2023.02.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Revised: 12/02/2022] [Accepted: 02/02/2023] [Indexed: 03/18/2023]
Abstract
OBJECTIVES Examine differences in multidimensional well-being from before (January 2020) to three timepoints during the COVID-19 pandemic (June 2020, January 2021, January 2022). STUDY DESIGN Repeated cross-sectional design. METHODS Nationally representative cross-sectional cohorts of US adults completed the Secure Flourish Index before (January 2020 cohort: N = 1010) and during the COVID-19 pandemic (June 2020 cohort: N = 3020; January 2021 cohort: N = 3366; January 2022 cohort: N = 2598). We estimated differences in indicators, domains, and composite well-being between the January 2020 cohort and each of the subsequent cohorts. We also explored whether changes in well-being between January 2020 and January 2022 varied based on age, gender, and race/ethnicity. RESULTS Initial declines in well-being observed by June 2020 were largely followed by a return to prepandemic levels in January 2022, with some exceptions. Notably, general declines in mental health have persisted through to January 2022. On the other hand, there was evidence of general improvements in character & virtue that exceeded prepandemic levels in January 2022. Young adults and racial/ethnic minorities reported lower financial & material stability in January 2022 compared to before the COVID-19 pandemic. CONCLUSIONS Although there are promising signs that the well-being of US adults has mostly recovered to prepandemic levels, a coordinated response is urgently needed to support population mental health and the financial security of vulnerable groups. As society continues the journey toward postpandemic recovery, continued tracking of multidimensional well-being will be important for making informed decisions about public health priorities.
Collapse
Affiliation(s)
- R G Cowden
- Human Flourishing Program, Institute for Quantitative Social Science, Harvard University, Cambridge, MA, USA.
| | - J S Nakamura
- Department of Psychology, University of British Columbia, Vancouver, BC, Canada
| | | | - Y Chen
- Human Flourishing Program, Institute for Quantitative Social Science, Harvard University, Cambridge, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - J Fulks
- American Bible Society, Philadelphia, PA, USA; Evangel University, Springfield, MO, USA
| | - J F Plake
- American Bible Society, Philadelphia, PA, USA
| | - T J VanderWeele
- Human Flourishing Program, Institute for Quantitative Social Science, Harvard University, Cambridge, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| |
Collapse
|
27
|
Xiao Y, Brown TT, Snowden LR, Chow JCC, Mann JJ. COVID-19 Policies, Pandemic Disruptions, and Changes in Child Mental Health and Sleep in the United States. JAMA Netw Open 2023; 6:e232716. [PMID: 36912834 DOI: 10.1001/jamanetworkopen.2023.2716] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/14/2023] Open
Abstract
IMPORTANCE The adverse effects of COVID-19 containment policies disrupting child mental health and sleep have been debated. However, few current estimates correct biases of these potential effects. OBJECTIVES To determine whether financial and school disruptions related to COVID-19 containment policies and unemployment rates were separately associated with perceived stress, sadness, positive affect, COVID-19-related worry, and sleep. DESIGN, SETTING, AND PARTICIPANTS This cohort study was based on the Adolescent Brain Cognitive Development Study COVID-19 Rapid Response Release and used data collected 5 times between May and December 2020. Indexes of state-level COVID-19 policies (restrictive, supportive) and county-level unemployment rates were used to plausibly address confounding biases through 2-stage limited information maximum likelihood instrumental variables analyses. Data from 6030 US children aged 10 to 13 years were included. Data analysis was conducted from May 2021 to January 2023. EXPOSURES Policy-induced financial disruptions (lost wages or work due to COVID-19 economic impact); policy-induced school disruptions (switches to online or partial in-person schooling). MAIN OUTCOMES AND MEASURES Perceived stress scale, National Institutes of Health (NIH)-Toolbox sadness, NIH-Toolbox positive affect, COVID-19-related worry, and sleep (latency, inertia, duration). RESULTS In this study, 6030 children were included in the mental health sample (weighted median [IQR] age, 13 [12-13] years; 2947 [48.9%] females, 273 [4.5%] Asian children, 461 [7.6%] Black children, 1167 [19.4%] Hispanic children, 3783 [62.7%] White children, 347 [5.7%] children of other or multiracial ethnicity). After imputing missing data, experiencing financial disruption was associated with a 205.2% [95% CI, 52.9%-509.0%] increase in stress, a 112.1% [95% CI, 22.2%-268.1%] increase in sadness, 32.9% [95% CI, 3.5%-53.4%] decrease in positive affect, and a 73.9 [95% CI, 13.2-134.7] percentage-point increase in moderate-to-extreme COVID-19-related worry. There was no association between school disruption and mental health. Neither school disruption nor financial disruption were associated with sleep. CONCLUSIONS AND RELEVANCE To our knowledge, this study presents the first bias-corrected estimates linking COVID-19 policy-related financial disruptions with child mental health outcomes. School disruptions did not affect indices of children's mental health. These findings suggest public policy should consider the economic impact on families due to pandemic containment measures, in part to protect child mental health until vaccines and antiviral drugs become available.
Collapse
Affiliation(s)
- Yunyu Xiao
- Weill Cornell Medicine, NewYork Presbyterian, Department of Population Health Sciences, New York
| | | | | | | | - J John Mann
- Departments of Psychiatry and Radiology, Columbia University Irving Medical Center, Columbia University, New York
- Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, New York
| |
Collapse
|
28
|
Ettman CK, Fan AY, Subramanian M, Adam GP, Badillo Goicoechea E, Abdalla SM, Stuart EA, Galea S. Prevalence of depressive symptoms in U.S. adults during the COVID-19 pandemic: A systematic review. SSM Popul Health 2023; 21:101348. [PMID: 36741588 PMCID: PMC9883077 DOI: 10.1016/j.ssmph.2023.101348] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2022] [Revised: 01/16/2023] [Accepted: 01/20/2023] [Indexed: 01/30/2023] Open
Abstract
The COVID-19 pandemic has led to a worsening of mental health among U.S. adults. However, no review to date has synthesized the overall prevalence of population depressive symptoms in the U.S. over the COVID-19 pandemic. We aimed to document the population prevalence of depressive symptoms and psychological distress across time since the start of the COVID-19 pandemic, both to identify patterns that emerged in the literature and to assess the data sources, methods, sampling, and measurement used to examine population mental health during the pandemic. In a systematic review of the peer review literature, we identified 49 articles reporting 88 prevalence points of depressive symptoms and related constructs in nationally representative samples of U.S. adults from March 2020 to June 2021. First, we found that the average prevalence of poor mental health across studies was 12.9% for severe depression, 26.0% for at least moderate depression, and 36.0% for at least mild depression. Second, we found that women reported significantly higher prevalence of probable depression than men in 63% of studies that reported depression levels by gender and that results on statistically significant differences between racial and ethnic groups were mixed. Third, we found that the 49 articles published were based on 12 studies; the most common sources were the Household Pulse Survey (n = 15, 31%), the AmeriSpeak panel (n = 8, 16%), the Qualtrics panel (n = 8, 16%), and the Understanding America Study (n = 5, 10%). Prevalence estimates varied based on mental health screening instruments and cutoffs used. The most commonly used instruments were the Patient Health Questionnaire (PHQ) (n = 36, 73%) and the Kessler (n = 8, 16%) series. While the prevalence of population depression varied over time depending on the survey instruments, severity, and constructs reported, the overall prevalence of depression remained high from March 2020 through June 2021 across instruments and severity. Understanding the scope of population mental health can help policymakers and providers address and prepare to meet the ongoing and future mental health needs of U.S. adults in the post-COVID-19 context and beyond.
Collapse
Affiliation(s)
- Catherine K. Ettman
- Johns Hopkins Bloomberg School of Public Health, USA
- Boston University School of Public Health, USA
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Hale S, Myerson J, Strube MJ, Green L, Lewandowski AB. Distress Signals: Age Differences in Psychological Distress before and during the COVID-19 Pandemic. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:3549. [PMID: 36834239 PMCID: PMC9964389 DOI: 10.3390/ijerph20043549] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/29/2022] [Revised: 02/10/2023] [Accepted: 02/13/2023] [Indexed: 06/18/2023]
Abstract
Psychological distress reached historically high levels in 2020, but why, and why were there pronounced age differences? We address these questions using a relatively novel, multipronged approach, part narrative review and part new data analyses. We first updated previous analyses of national surveys that showed distress was increasing in the US and Australia through 2017 and then re-analyzed data from the UK, comparing periods with and without lockdowns. We also analyzed the effects of age and personality on distress in the US during the pandemic. Results showed distress levels and age differences in distress were still increasing through 2019 in the US, UK, and Australia. The effects of lockdowns in 2020 revealed the roles of social deprivation and fear of infection. Finally, age-related differences in emotional stability accounted for the observed age differences in distress. These findings reveal the limitations of analyses comparing pre-pandemic and pandemic periods without accounting for ongoing trends. They also suggest that differences in personality traits such as emotional stability modulate responses to stressors. This could explain age and individual differences in both increases and decreases in distress in response to changes in the level of stressors such as those occurring prior to and during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Sandra Hale
- Department of Psychological & Brain Sciences, Washington University in St. Louis, St. Louis, MO 63130, USA
| | | | | | | | | |
Collapse
|
30
|
Zimmerman M, D'Avanzato C, King BT. Telehealth treatment of patients with major depressive disorder during the COVID-19 pandemic: Comparative safety, patient satisfaction, and effectiveness to prepandemic in-person treatment. J Affect Disord 2023; 323:624-630. [PMID: 36521663 PMCID: PMC9742046 DOI: 10.1016/j.jad.2022.12.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2022] [Revised: 12/02/2022] [Accepted: 12/05/2022] [Indexed: 12/14/2022]
Abstract
BACKGROUND The COVID-19 pandemic impelled a transition from in-person to telehealth psychiatric treatment. There are no studies of partial hospital telehealth treatment for major depressive disorder (MDD). In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we compared the effectiveness of partial hospital care of patients with MDD treated virtually versus in-person. METHODS Outcome was compared in 294 patients who were treated virtually from May 2020 to December 2021 to 542 patients who were treated in the in-person partial program in the 2 years prior to the pandemic. Patients completed self-administered measures of patient satisfaction, symptoms, coping ability, functioning, and general well-being. RESULTS In both the in-person and telehealth groups, patients with MDD were highly satisfied with treatment and reported a significant reduction in symptoms from admission to discharge. Both groups also reported a significant improvement in positive mental health, general well-being, coping ability, and functioning. A large effect size of treatment was found in both treatment groups. Contrary to our hypothesis, the small differences in outcome favored the telehealth-treated patients. The length of stay and the likelihood of staying in treatment until completion were significantly greater in the virtually treated patients. LIMITATIONS The treatment groups were ascertained sequentially, and telehealth treatment was initiated after the COVID-19 pandemic began. Outcome assessment was limited to a self-administered questionnaire. CONCLUSIONS In an intensive acute care setting, delivering treatment to patients with MDD using a virtual, telehealth platform was as effective as treating patients in-person.
Collapse
Affiliation(s)
- Mark Zimmerman
- Department of Psychiatry and Human Behavior, Brown Medical School, Rhode Island Hospital, Providence, RI, United States.
| | - Catherine D'Avanzato
- Department of Psychiatry and Human Behavior, Brown Medical School, Rhode Island Hospital, Providence, RI, United States
| | - Brittany T King
- Department of Psychiatry and Human Behavior, Brown Medical School, Rhode Island Hospital, Providence, RI, United States
| |
Collapse
|
31
|
Oyeka O, Wehby GL. Effects of the Affordable Care Act Medicaid Expansions on Mental Health During the COVID-19 Pandemic in 2020-2021. INQUIRY : A JOURNAL OF MEDICAL CARE ORGANIZATION, PROVISION AND FINANCING 2023; 60:469580231166738. [PMID: 37052143 PMCID: PMC10102829 DOI: 10.1177/00469580231166738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
Abstract
To examine whether previous Affordable Care Act (ACA) Medicaid expansions had an added effect on the mental health of low-income adults during the COVID-19 pandemic in 2020 and 2021. We use the 2017-2021 Behavioral Risk Factor Surveillance System (BRFSS) data. We use an event study difference-in-differences model to compare the number of days in poor mental health in the past 30 days and the likelihood of frequent mental distress among 18 to 64 year old individuals with household incomes below 100% of the federal poverty level who participated in BRFSS in one of the surveys from 2017 to 2021 and who resided in states that expanded Medicaid by 2016 or states that had not expanded by 2021. We also examine the heterogeneity of the expansion effects across subpopulation groups. We find some evidence that the Medicaid expansion was associated with better mental health during the pandemic for adults younger than 45, females, and non-Hispanic Black and other non-Hispanic non-White individuals. There is some evidence of an added benefit to mental health from Medicaid expansion status during the pandemic for some subgroups among low-income adults, suggesting potential health benefits from Medicaid eligibility during public health and economic crises.
Collapse
Affiliation(s)
| | - George L Wehby
- University of Iowa, Iowa City, IA, USA
- National Bureau of Economic Research, Cambridge, MA, USA
| |
Collapse
|
32
|
Bauer AE, Guintivano J, Krohn H, Sullivan PF, Meltzer-Brody S. The longitudinal effects of stress and fear on psychiatric symptoms in mothers during the COVID-19 pandemic. Arch Womens Ment Health 2022; 25:1067-1078. [PMID: 36151337 PMCID: PMC9510199 DOI: 10.1007/s00737-022-01265-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Accepted: 09/06/2022] [Indexed: 12/14/2022]
Abstract
The COVID-19 pandemic has been particularly difficult for mothers. Women with a history of peripartum depression (PPD) may be vulnerable to relapse. We sought to understand changes in depressive and anxious symptoms throughout the pandemic and which stressors increased symptoms in women with a history of PPD. In June 2020, all US participants with a history of PPD (n = 12,007) in the global MomGenes Fight PPD study were invited to the COVID-19 follow-up study. Respondents (n = 2163, 18%) were sent biweekly and then monthly surveys until January 31, 2022. We employed time-varying effects models to evaluate trajectories of depressive (patient health questionnaire, PHQ-9) and anxious (generalized anxiety disorder, GAD-7) symptoms and to estimate longitudinal associations between perceived stress, fears, COVID-19 case rates, and symptoms. Peaks of PHQ-9, GAD-7, PSS, and perceived COVID-19 risk scores corresponded with timing of national COVID-19 case surges. High perceived stress was the strongest predictor of PHQ-9 (beta = 7.27; P = 1.48e - 38) and GAD-7 (beta = 7.73; P = 6.19e - 70). Feeling lack of control and unlikely to survive increased PHQ-9 and GAD-7 scores by 2 points. COVID-19 case rates, pandemic restrictions, and region were not independently associated with symptoms. This study suggests that the collective trauma of the pandemic has significantly affected mothers with a history of PPD, exemplified by high levels of perceived stress and the strong association with depressive and anxious symptoms. The next pandemic phase is uncertain, but will continue to influence mental health collectively and dynamically. Interventions must be flexible and responsive and should address fear, trauma, and feelings of control, particularly for mothers with a history of PPD.
Collapse
Affiliation(s)
- Anna E Bauer
- Department of Psychiatry, University of North Carolina at Chapel Hill, CB #7160, 234 Medical Wing C, Chapel Hill, NC, 27599, USA.
| | - Jerry Guintivano
- Department of Psychiatry, University of North Carolina at Chapel Hill, CB #7160, 234 Medical Wing C, Chapel Hill, NC, 27599, USA
| | - Holly Krohn
- Department of Psychiatry, University of North Carolina at Chapel Hill, CB #7160, 234 Medical Wing C, Chapel Hill, NC, 27599, USA
| | - Patrick F Sullivan
- Department of Psychiatry, University of North Carolina at Chapel Hill, CB #7160, 234 Medical Wing C, Chapel Hill, NC, 27599, USA
- Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - Samantha Meltzer-Brody
- Department of Psychiatry, University of North Carolina at Chapel Hill, CB #7160, 234 Medical Wing C, Chapel Hill, NC, 27599, USA
| |
Collapse
|
33
|
Ruhm CJ. Pandemic And Recession Effects On Mortality In The US During The First Year Of COVID-19. Health Aff (Millwood) 2022; 41:1550-1558. [DOI: 10.1377/hlthaff.2022.00364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
34
|
Kessler RC, Ruhm CJ, Puac-Polanco V, Hwang IH, Lee S, Petukhova MV, Sampson NA, Ziobrowski HN, Zaslavsky AM, Zubizarreta JR. Estimated Prevalence of and Factors Associated With Clinically Significant Anxiety and Depression Among US Adults During the First Year of the COVID-19 Pandemic. JAMA Netw Open 2022; 5:e2217223. [PMID: 35704316 PMCID: PMC9201669 DOI: 10.1001/jamanetworkopen.2022.17223] [Citation(s) in RCA: 39] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Accepted: 04/27/2022] [Indexed: 11/14/2022] Open
Abstract
Importance Claims of dramatic increases in clinically significant anxiety and depression early in the COVID-19 pandemic came from online surveys with extremely low or unreported response rates. Objective To examine trend data in a calibrated screening for clinically significant anxiety and depression among adults in the only US government benchmark probability trend survey not disrupted by the COVID-19 pandemic. Design, Setting, and Participants This survey study used the US Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System (BRFSS), a monthly state-based trend survey conducted over the telephone. Participants were adult respondents in the 50 US states and District of Columbia who were surveyed March to December 2020 compared with the same months in 2017 to 2019. Exposures Monthly state COVID-19 death rates. Main Outcomes and Measures Estimated 30-day prevalence of clinically significant anxiety and depression based on responses to a single BRFSS item calibrated to a score of 6 or greater on the 4-item Patient Health Questionnaire (area under the receiver operating characteristic curve, 0.84). All percentages are weighted based on BRFSS calibration weights. Results Overall, there were 1 429 354 respondents, with 1 093 663 in 2017 to 2019 (600 416 [51.1%] women; 87 153 [11.8%] non-Hispanic Black; 826 334 [61.5%] non-Hispanic White; 411 254 [27.8%] with college education; and 543 619 [56.8] employed) and 335 691 in 2020 (182 351 [51.3%] women; 25 517 [11.7%] non-Hispanic Black; 250 333 [60.5%] non-Hispanic White; 130 642 [29.3%] with college education; and 168 921 [54.9%] employed). Median within-state response rates were 45.9% to 49.4% in 2017 to 2019 and 47.9% in 2020. Estimated 30-day prevalence of clinically significant anxiety and depression was 0.4 (95% CI, 0.0 to 0.7) percentage points higher in March to December 2020 (12.4%) than March to December 2017 to 2019 (12.1%). This estimated increase was limited, however, to students (2.4 [95% CI, 0.8 to 3.9] percentage points) and the employed (0.9 [95% CI, 0.5 to 1.4] percentage points). Estimated prevalence decreased among the short-term unemployed (-1.8 [95% CI, -3.1 to -0.5] percentage points) and those unable to work (-4.2 [95% CI, -5.3 to -3.2] percentage points), but did not change significantly among the long-term unemployed (-2.1 [95% CI, -4.5 to 0.5] percentage points), homemakers (0.8 [95% CI, -0.3 to 1.9] percentage points), or the retired (0.1 [95% CI, -0.6 to 0.8] percentage points). The increase in anxiety and depression prevalence among employed people was positively associated with the state-month COVID-19 death rate (1.8 [95% CI, 1.2 to 2.5] percentage points when high and 0.0 [95% CI, -0.7 to 0.6] percentage points when low) and was elevated among women compared with men (2.0 [95% CI, 1.4 to 2.5] percentage points vs 0.2 [95% CI, -0.1 to 0.6] percentage points), Non-Hispanic White individuals compared with Hispanic and non-Hispanic Black individuals (1.3 [95% CI, 0.6 to 1.9] percentage points vs 1.1 [95% CI, -0.2 to 2.5] percentage points and 0.7 [95% CI, -0.1 to 1.5] percentage points), and those with college educations compared with less than high school educations (2.5 [95% CI, 1.9 to 3.1] percentage points vs -0.6 [95% CI, -2.7 to 1.4] percentage points). Conclusions and Relevance In this survey study, clinically significant US adult anxiety and depression increased less during 2020 than suggested by online surveys. However, this modest aggregate increase could mask more substantial increases in key population segments (eg, first responders) and might have become larger in 2021 and 2022.
Collapse
Affiliation(s)
- Ronald C. Kessler
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
| | - Christopher J. Ruhm
- Frank Batten School of Leadership & Public Policy, University of Virginia, Charlottesville
| | - Victor Puac-Polanco
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
| | - Irving H. Hwang
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
| | - Sue Lee
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
| | - Maria V. Petukhova
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
| | - Nancy A. Sampson
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
| | | | - Alan M. Zaslavsky
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
| | - Jose R. Zubizarreta
- Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
- Department of Statistics, Harvard University, Cambridge, Massachusetts
- Department of Biostatistics, Harvard Chan School of Public Health, Boston, Massachusetts
| |
Collapse
|
35
|
Sotille R, Singh H, Weisman A, Vida T. Unraveling the Mysteries of Mental Illness With Psilocybin. Cureus 2022; 14:e25414. [PMID: 35769681 PMCID: PMC9233936 DOI: 10.7759/cureus.25414] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/26/2022] [Indexed: 12/23/2022] Open
Abstract
Current medications have not been effective in reducing the prevalence of mental illness worldwide. The prevalence of illnesses such as treatment-resistant depression has increased despite the widespread use of a broad set of psychopharmaceuticals. Transcranial magnetic stimulation and ketamine therapy are making great strides in improving treatment-resistant depression outcomes but they have limitations. New psychotherapeutics are required that specifically target the underlying cellular pathologies leading to neuronal atrophy. This neuronal atrophy model is supplanting the long-held neurotransmitter deficit hypothesis to explain mental illness. Interest in psychedelics as therapeutic molecules to treat mental illness is experiencing a 21st-century reawakening that is on the cusp of a transformation. Psilocybin is a pro-drug, found in various naturally occurring mushrooms, that is dephosphorylated to produce psilocin, a classic tryptamine psychedelic functional as a 5-hydroxytryptamine 2A receptor agonist. We have focused this review to include studies in the last two years that suggest psilocybin promotes neuronal plasticity, which may lead to changes in brain network connectivity. Recent advancements in clinical trials using pure psilocybin in therapy suggest that it may effectively relieve the symptoms of depression in patients diagnosed with major depressive disorder and treatment-resistant depression. Sophisticated cellular and molecular experiments at the systems level have produced evidence that demonstrates psilocybin promotes neuritogenesis in the mouse brain - a mechanism that may address the root cause of depression at the cellular level. Finally, studies with psilocybin therapy for major depressive disorder suggest that this ancient molecule can promote functionally connected intrinsic networks in the human brain, resulting in durable improvements in the severity of depressive symptoms. Although further research is necessary, the prospect of using psilocybin for the treatment of mental illness is an enticing possibility.
Collapse
Affiliation(s)
- Robert Sotille
- Medical Education, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, USA
| | - Herpreet Singh
- Medical Education, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, USA
| | - Anne Weisman
- Medical Education, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, USA
| | - Thomas Vida
- Medical Education, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, USA
| |
Collapse
|